Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-21-086943
Filing Date
2021-06-29
Accepted
2021-06-29 17:21:54
Documents
1
Period of Report
2021-06-25

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2119762-6_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2119762-6_4seq1.xml 4 4402
  Complete submission text file 0001104659-21-086943.txt   5948
Mailing Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511
Business Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511 203-643-8060
BioXcel Therapeutics, Inc. (Issuer) CIK: 0001720893 (see all company filings)

EIN.: 821386754 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2614 BOSTON POST ROAD, SUITE 33B GUILFORD CT 06437
Business Address 2614 BOSTON POST ROAD, SUITE 33B GUILFORD CT 06437 203-643-8060
BioXcel Holdings, Inc. (Reporting) CIK: 0001811154 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-38410 | Film No.: 211059222